Non-IgE-mediated food allergies by Terblanche, A J et al.
CONTINUING MEDICAL EDUCATION
       January 2015, Vol. 105, No. 1
Non-imunoglobulin E (IgE)-mediated conditions 
include combined IgE and cell-mediated conditions 
such as atopic dermatitis (AD) and eosinophilic 
oesophagitis (EoE), and pure T-cell-mediated 
conditions such as food protein-induced enterocolitis 
syndrome (FPIES), allergic proctocolitis and enteropathy syndromes.
Diagnostic tests in non-IgE-mediated 
food allergy
Diagnosing mixed or non-IgE-mediated allergy is challenging. A 
clear cause-effect relationship between exposure to the suspected 
food and symptoms is not always possible, as symptoms develop over 
time and are more chronic in nature. Skin-prick tests (SPTs) and 
specific IgE (sIgE) to the allergen are usually negative. An elimination 
diet may be necessary to diagnose non-IgE-mediated type food 
allergy. The suspected allergen should be excluded from the diet for 
2 - 6 weeks under dietetic guidance to assess for improvement of 
symptoms. After symptom improvement, a rechallenge is necessary 
to definitively prove causal relation.
Endoscopy with biopsies to show bowel inflammation is often 
helpful especially in EoE. Currently evidence for atopy patch testing 
(APT) is not convincing.[1-3]
Combined IgE- and cell-mediated 
food allergic conditions
Atopic dermatitis (AD)
AD is associated with food allergy in 35% of children with moderate-
to-severe skin rash.[4] The majority of reactions are IgE-mediated and in 
those with reactions, approximately 10% (i.e. 3 - 4% of total) have isolated 
flares of eczema without any IgE-mediated symptoms. The prevalence is 
much lower in patients with less severe disease and in adults.
Investigations for food allergy are not routine in all cases of AD. 
Concomitant or causative food allergy should be considered in those 
patients with a convincing history of food allergy and those with 
moderate-to-severe eczema that does not respond to appropriate and 
adequate topical treatment.[5] The diagnostic workup for IgE-mediated 
food allergy in the setting of eczema is the same as for IgE-mediated 
food allergy without eczema. Patients being worked up for eczema 
flares alone should be referred for full allergy assessment prior to 
considering any dietary modification. Eczema patients are often 
multiply sensitised, but tolerant to those foods, so the diagnostic 
workup for food allergy triggering isolated flares of eczema centres 
primarily on elimination and rechallenge testing to prove causality.
Eosinophilic oesophagitis (EoE)
Multiple food allergens are implicated in this disorder manifested by 
feeding disorders, reflux symptoms, vomiting, dysphagia and food 
impaction.[1,6] The variety of symptoms is experienced mostly after 
eating. In children, the age of presentation influences the complex of 
symptoms. Very young children present with feeding difficulties and 
failure to thrive, older children present with vomiting and abdominal 
pain, and teenagers with dysphagia and food impaction.[7,8] Other 
allergic diseases are often present. Food allergens and aeroallergens 
may play a significant role in the pathophysiology. SPT, sIgE and APT 
may be used to help identify associated foods, but these tests alone are 
not sufficient to make the diagnosis.[3] 
Upper endoscopy with multiple (2 - 4) biopsies from both the proximal 
and distal oesophagus (4 - 8 in total) is recommended.[9,10] Eosinophilia 
due to gastro-oesophageal reflux disease should be eliminated by prior 
treatment with proton-pump inhibitors for at least 6 weeks. The 
diagnosis is confirmed with oesophageal biopsy showing more than 
15 eosinophils per high-powered field in the presence of typical 
symptoms. Other disorders with eosinophilia like Crohn’s, coeliac 
disease or achalasia should be excluded. 
Management of EoE
Dietary aspects[11]
Elimination diets may be an effective therapy for EoE. 
There are 3 approaches for dietary elimination:
• total elimination of all food allergens with feeding exclusively on 
an elemental or amino-acid-based formula
• targeted elimination of specific foods as guided by allergy testing, 
usually SPT or patch testing
• an empirical six-food elimination diet removing the six most 
common food allergens that are triggers for EoE: soy, egg, milk, 
wheat, nuts and seafood.
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The duration of the treatment is usually 4 - 8 weeks, followed by a 
stepwise re-introduction period once remission has been achieved. 
Foods are re-introduced every 5 - 7 days and the most allergenic 
foods in EoE (such as milk, egg, wheat, soy, beef and peanuts) are left 
until last. Repeat oesophagoscopy and biopsies are done if symptoms 
recur. Some centres recommend periodic endoscopy and biopsy after 
re-introduction of 3 - 4 foods to confirm histological remission.
Food manipulation is not successful in all patients and some require 
pharmacotherapy in addition to, or instead of, dietary manipulation.
Pharmacological therapy
Not all cases of EoE are suitable for dietary therapy. The patient 
may not be prepared to accept the dietary restrictions or may fail 
to respond to this approach. A subgroup of EoE cases appears to 
be sensitised to aeroallergens; these cases tend to have seasonal 
symptoms and may need medication to alleviate symptoms.
The mainstay of drug therapy is the topical administration of 
corticosteroids, although proton-pump inhibitors have a role to play:
Proton-pump inhibitor therapy. Because reflux may cause 
oesophageal eosinophilia and be mistaken for EoE, it is critical to 
treat reflux, even where not proven, prior to oesophageal biopsy. 
In addition, reflux may be a result of EoE, therefore proton-pump 
inhibitors also have a role in treating established EoE.
Corticosteroids. Corticosteroids are an effective therapy and 
improve the clinicopathological features of EoE; however, when 
discontinued, the disease often recurs. 
• Topical corticosteroids. Topical corticosteroids have been shown 
to be effective in inducing clinical and histological response (and 
remission) in children and adults with EoE. Two preparations 
have been assessed, viz. swallowed fluticasone proprionate and 
oral viscous budesonide.[6,10] Topical therapy has relatively few 
side-effects although fungal infection (Candida) is a recognised 
potential complication.
• Systemic corticosteroids. Although highly effective, the side-effects 
of oral therapy limit its use to short courses in severely affected 
cases. Systemic (oral) steroids should only be used in emergency 
cases when rapid improvement of symptoms is needed, e.g. severe 
dysphagia, weight loss or oesophageal strictures, or when topical 
steroids have been ineffective.[6,10] 
Other medical therapy 
The following additional medications have not been shown to be of 
consistent benefit and none can therefore currently be recommended as 
routine treatment for children with EoE:[6,10]
• leukotriene antagonists 
• cromolyn sodium
• omalizumab
• anti-interleukin-5 antibodies (mepolizumab, reslizumab )
• azathioprine, 6-mercaptopurine and antitumour necrosis factor.
Oesophageal dilation 
Oesophageal strictures, which are a recognised complication of EoE, 
can be effectively managed with oesophageal dilation but this does 
not improve the underlying inflammatory process.
Eosinophilic gastroenteritis (EG)
Patients with EG may present at any age, and any portion of 
the gastrointestinal tract, from the oesophagus to the colon, 
may be involved,[12] with symptoms varying according to the 
site of significant eosinophilic inflammation. These may include 
ascites, nausea, diarrhoea, malabsorption, weight loss, oedema and 
obstruction.[1] Infants may present with projectile vomiting as a 
result of gastric outlet obstruction. Adolescents on the other hand 
may present with symptoms similar to irritable bowel syndrome. 
Like in EoE, 50% of patients with EG have other atopic diseases.[12] 
In some cases, especially in young patients, food allergens may be 
implicated.
Cell-mediated food allergic conditions
Food protein-induced enterocolitis syndrome (FPIES)
FPIES occurs primarily in infants younger than 9 months of age. 
It is a severe disease caused predominantly by cow’s milk and soy. 
Any food may however be implicated, and cases caused by rice, oats, 
meat, chicken and some vegetables are described. In the classic form 
dietary exposure causes severe emesis, diarrhoea and hypotension 
(in 15%) approximately 2 hours after ingestion.[1] Patients often 
present to the emergency room with severe dehydration and 
hypotension. A milder, more chronic form may present with emesis, 
diarrhoea, poor growth, anaemia, hypoproteinaemia and lethargy. 
Contrary to food protein-induced allergic proctocolitis, FPIES 
rarely occurs in breastfed infants. Symptoms improve promptly on 
removal of the culprit food, but it may take weeks for the T-cell-
mediated inflammation to resolve totally. The prognosis is good and 
tolerance to the allergens is usually attained by the age of 3 years. 
Oral food challenge should be performed at that time to confirm 
resolution and tolerance.[12] Such challenges must be considered 
high-risk challenges and be performed in a hospital setting with 
intravenous access and a modified protocol with lower doses and 
longer periods between introduction of foods. 
Food protein-induced allergic proctocolitis
In food protein-induced allergic proctocolitis, healthy infants present 
with mucus-laden bloody stools within the first few weeks to months 
of life. Cow’s milk protein is usually implicated, mostly in formula-fed 
infants and less commonly through transfer in breastmilk. Change 
of formula to an elemental formula or restriction of cow’s milk from 
the maternal diet usually results in resolution of symptoms within 48 
hours. The condition has a good prognosis and usually resolves at the 
end of the first year of life.[1,12] 
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